PHYSICIANS RLTY TR (DOCXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$11
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $11 | 1 | 0.00% | 15q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $172.7K | 10,801 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 2 | $205.6K | 10,801 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 3 | $5.0M | 283,344 | 0 | 0 | 1 | 0.0% |
| Q1 2025 | 3 | $5.9M | 290,605 | 0 | 0 | 1 | 0.0% |
| Q4 2024 | 4 | $10.1M | 496,443 | 1 | 1 | 0 | 0.0% |
| Q3 2024 | 4 | $6.8M | 295,468 | 2 | 0 | 0 | 0.0% |
| Q2 2024 | 3 | $439.9K | 22,445 | 1 | 0 | 1 | 0.0% |
| Q1 2024 | 7 | $7.7M | 416,271 | 1 | 2 | 3 | 0.0% |
| Q4 2023 | 299 | $2.8B | 212,138,054 | 42 | 87 | 105 | 0.1% |
| Q3 2023 | 312 | $2.7B | 219,589,553 | 24 | 92 | 123 | 0.1% |
| Q2 2023 | 304 | $3.1B | 224,158,374 | 25 | 129 | 83 | 0.2% |
| Q1 2023 | 295 | $3.3B | 218,247,765 | 36 | 119 | 68 | 0.2% |
| Q4 2022 | 264 | $2.7B | 186,869,499 | 34 | 91 | 82 | 0.1% |
| Q3 2022 | 348 | $3.2B | 212,649,826 | 29 | 140 | 105 | 0.2% |
| Q2 2022 | 347 | $3.7B | 212,050,893 | 43 | 124 | 100 | 0.2% |
| Q1 2022 | 342 | $3.6B | 204,435,899 | 27 | 127 | 106 | 1.2% |
| Q4 2021 | 354 | $3.8B | 198,473,193 | 39 | 141 | 99 | 1.0% |
| Q3 2021 | 337 | $3.4B | 191,287,377 | 30 | 124 | 92 | 0.2% |
| Q2 2021 | 340 | $3.6B | 193,591,342 | 30 | 141 | 101 | 0.2% |
| Q1 2021 | 351 | $3.4B | 190,186,765 | 38 | 134 | 110 | 0.2% |
| Q4 2020 | 345 | $3.5B | 194,877,443 | 40 | 106 | 118 | 0.3% |
| Q3 2020 | 330 | $3.5B | 195,972,072 | 35 | 121 | 96 | 0.1% |
| Q2 2020 | 323 | $3.5B | 201,464,980 | 59 | 119 | 95 | 0.1% |
| Q1 2020 | 317 | $2.6B | 187,613,446 | 60 | 112 | 99 | 0.1% |
| Q4 2019 | 294 | $3.3B | 174,869,837 | 33 | 100 | 85 | 0.1% |
| Q3 2019 | 275 | $3.1B | 172,996,843 | 30 | 88 | 91 | 0.1% |
| Q2 2019 | 269 | $3.2B | 185,948,735 | 26 | 99 | 89 | 0.2% |
| Q1 2019 | 281 | $3.4B | 180,645,004 | 39 | 108 | 83 | 0.1% |
| Q4 2018 | 269 | $2.8B | 172,677,614 | 5 | 5 | 3 | 0.1% |